Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Role of iodine-containing multivitamins during pregnancy for childrens brain function: protocol of an ongoing randomised controlled trial: the SWIDDICH study
Univ Gothenburg, Sweden; Kungälvs Hosp, Sweden.
Univ Gothenburg, Sweden.
Umea Univ, Sweden; Med Univ Warsaw, Poland.
Univ Gothenburg, Sweden.
Show others and affiliations
2018 (English)In: BMJ Open, ISSN 2044-6055, E-ISSN 2044-6055, Vol. 8, no 4, article id e019945Article in journal (Refereed) Published
Abstract [en]

Introduction Iodine is essential for normal brain development. Moderate and severe fetal iodine deficiency results in substantial to serious developmental delay in children. Mild iodine deficiency in pregnancy is associated with neurodevelopmental deficits in the offspring, but evidence from randomised trials is lacking. The aim of the Swedish Iodine in Pregnancy and Development in Children study is to determine the effect of daily supplementation with 150 mu g iodine during pregnancy on the offsprings neuropsychological development up to 14 years of age. Methods and analysis Thyroid healthy pregnant women (n=1275: age range 18- 40 years) at amp;lt;= 12 weeks gestation will be randomly assigned to receive multivitamin supplements containing 150 mu g iodine or non-iodine-containing multivitamin daily throughout pregnancy. As a primary outcome, IQ will be measured in the offspring at 7 years (Wechsler Intelligence Scale for Children-V). As secondary outcomes, IQ will be measured at 3.5 and 14 years, psychomotor development at 18 months and 7 years, and behaviour at 3.5, 7 and 14 years. Iodine status (urinary iodine concentration) will be measured during pregnancy and in the offspring at 3.5, 7 and 14 years. Thyroid function (thyroid hormones, thyroglobulin), and deiodinase type 2 polymorphisms will be measured during pregnancy and in the offspring at 7 and 14 years. Structural MRI or other relevant structural or functional brain imaging procedures will be performed in a subgroup of children at 7 and 14 years. Background and socioeconomic information will be collected at all follow-up times. Ethics and dissemination This study is approved by the Ethics Committee in Goteborg, Sweden (Diary numbers: 431-12 approved 18 June 2012 (pregnancy part) and 1089-16 approved 8 February 2017 (children follow-up)). According to Swedish regulations, dietary supplements are governed by the National Food Agency and not by the Medical Product Agency. Therefore, there is no requirement for a monitoring committee and the National Food Agency does not perform any audits of trial conduct. The trial will be conducted in accordance with the Declaration of Helsinki. The participating sites will be contacted regarding important protocol changes, both orally and in writing, and the trial registry database will be updated accordingly. Study results will be presented at relevant conferences, and submitted to peer-reviewed journals with open access in the fields of endocrinology, paediatrics and nutrition. After the appropriate embargo period, the results will be communicated to participants, healthcare professionals at the maternal healthcare centres, the public and other relevant groups, such as the national guideline group for thyroid and pregnancy and the National Food Agency.

Place, publisher, year, edition, pages
BMJ PUBLISHING GROUP , 2018. Vol. 8, no 4, article id e019945
National Category
Pediatrics
Identifiers
URN: urn:nbn:se:liu:diva-149743DOI: 10.1136/bmjopen-2017-019945ISI: 000435176700117PubMedID: 29643159OAI: oai:DiVA.org:liu-149743DiVA, id: diva2:1234367
Note

Funding Agencies|ALF agreement [ALFGBG 58777, ALFGBG 717311]; Regional FOU [VGFOUREG 664301]; Lilla barnets fond [20160917]; Svenska Lakarsallskapet [SLS 688891]; Lars Hiertas Minne Foundation [FO2016 0016]; Formas grant [2017 0095]; General Maternity Hospital Foundation

Available from: 2018-07-24 Created: 2018-07-24 Last updated: 2019-04-30

Open Access in DiVA

fulltext(424 kB)14 downloads
File information
File name FULLTEXT01.pdfFile size 424 kBChecksum
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Gutefeldt, Kerstin
By organisation
Division of Cardiovascular MedicineFaculty of Medicine and Health SciencesDepartment of Endocrinology
In the same journal
BMJ Open
Pediatrics

Search outside of DiVA

GoogleGoogle Scholar
Total: 14 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 56 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf